Naltrexone Enhanced Addiction Treatment (NEAT): A randomised controlled trial of the clinical and cost-effectiveness of extended-release naltrexone and oral naltrexone

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-002584-25

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

A. Is XR-NTX treatment more effective than placebo at reducing heroin use? B. Is XR-NTX more effective than O-NTX at reducing heroin use? C. Is XR-NTX more cost- effective than placebo in terms of quality-adjusted life years? D. Is XR-NTX more cost-effective than O-NTX in terms of quality-adjusted life year?


Critère d'inclusion

  • Opiate Addiction

Liens